Prime Medicine, Inc. (PRME) stock
PRMENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.84−0.35 (-8.35%)
Close on Nov 17, 2026Market cap $696.49MP/E –Yield –
Prime Medicine market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Prime Medicine's market cap was $777.17M on Nov 11, 2026, against $688.78M a year earlier. Over the last 5 years it ranged from $154.77M to $1.60B, with a median of $648.85M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $777.17M | +24.2% |
| 2025 | Dec 31, 2025 | $625.67M | +63.4% |
| 2024 | Dec 31, 2024 | $382.99M | -55.6% |
| 2023 | Dec 29, 2023 | $862.29M | +38.3% |
| 2022 | Dec 30, 2022 | $623.54M | – |
See a number that looks wrong?